A personal (biased) perspective on cancer "vaccines".


The use of active specific immunotherapy (ASI) for cancer (cancer "vaccines") is still in its scientific infancy despite several decades of clinical and basic research. What has been established is the principle that stimulation of the immune response by "crude" (i.e., whole cell-derived) vaccines has led, in a proportion of patients, to rejection of tumor… (More)


Cite this paper

@article{Mitchell1997AP, title={A personal (biased) perspective on cancer "vaccines".}, author={Michael S. Mitchell}, journal={Oncology research}, year={1997}, volume={9 9}, pages={459-65} }